- Home
- TNK vs NVCR Comparison
TNK vs NVCR Comparison
Compare TNK & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNK
- NVCR
- Stock Information
- Founded
- TNK 2007
- NVCR 2000
- Country
- TNK Bermuda
- NVCR Switzerland
- Employees
- TNK N/A
- NVCR N/A
- Industry
- TNK Marine Transportation
- NVCR Medical/Dental Instruments
- Sector
- TNK Consumer Discretionary
- NVCR Health Care
- Exchange
- TNK Nasdaq
- NVCR Nasdaq
- Market Cap
- TNK 1.8B
- NVCR 1.4B
- IPO Year
- TNK 2007
- NVCR 2015
- Fundamental
- Price
- TNK $51.45
- NVCR $14.66
- Analyst Decision
- TNK Buy
- NVCR Buy
- Analyst Count
- TNK 3
- NVCR 7
- Target Price
- TNK $50.67
- NVCR $28.79
- AVG Volume (30 Days)
- TNK 503.3K
- NVCR 1.9M
- Earning Date
- TNK 10-29-2025
- NVCR 10-30-2025
- Dividend Yield
- TNK 3.89%
- NVCR N/A
- EPS Growth
- TNK N/A
- NVCR N/A
- EPS
- TNK 8.13
- NVCR N/A
- Revenue
- TNK $997,294,000.00
- NVCR $630,160,000.00
- Revenue This Year
- TNK N/A
- NVCR $6.68
- Revenue Next Year
- TNK $10.09
- NVCR $7.01
- P/E Ratio
- TNK $6.33
- NVCR N/A
- Revenue Growth
- TNK N/A
- NVCR 14.58
- 52 Week Low
- TNK $33.35
- NVCR $10.87
- 52 Week High
- TNK $62.45
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- TNK 50.90
- NVCR 72.10
- Support Level
- TNK $49.48
- NVCR $12.61
- Resistance Level
- TNK $55.18
- NVCR $14.17
- Average True Range (ATR)
- TNK 1.27
- NVCR 0.54
- MACD
- TNK -0.62
- NVCR 0.20
- Stochastic Oscillator
- TNK 31.77
- NVCR 98.65
About TNK Teekay Tankers Ltd.
Teekay Tankers Ltd is a provider of marine services to the international oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: Tankers, which consists of the operation of all of the company's tankers (including the operations from those tankers employed on full service lightering contracts), and the company's U.S. based ship-to-ship support service operations (including its lightering support services provided as part of full service lightering operations); and Marine Services, which consists of operational and maintenance marine services provided to the Australian government, Australian energy companies and other third parties. The company generates the majority of its revenue from the Tankers segment.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.